Philip Cotter earned his doctorate in Biomedical Sciences from the Department of Human Genetics at the Mount Sinai School of Medicine in New York. Dr. Cotter currently holds several positions, including a Principal of ResearchDx, LLC to ResearchDx, Inc. He is a Fellow, American College of Medical Genetics (FACMG) in Cytogenetics and Molecular Genetics and is a Board Certified by the American Board of Medical Genetics and Genomics in both Clinical Cytogenetics and Clinical Molecular Genetics. His Specialties: CLIA Laboratory Director. Additionally, He is a Fellow, Faculty of Science, Royal College of Pathologists of Australasia [FFSc(RCPA)]. Dr. Cotter has published extensively in the areas of cytogenetics, molecular genetics, and prenatal diagnosis.

Research Area: Clinical Consultant in Cytogeneics, Molecular Genetics, Molecular Oncology, Molecular Pathology and Next-Gen Sequencings